These are top 10 stocks traded on the Robinhood UK platform in July
PLANO, Texas - Integer Holdings Corporation (NYSE: ITGR), a prominent medical device contract development and manufacturing organization with a market capitalization of $4.2 billion and an overall "GREAT" financial health rating according to InvestingPro, announced the upcoming retirement of its President and Chief Executive Officer, Joseph Dziedzic. Effective October 24, 2025, Dziedzic will also step down from the Board of Directors. Payman Khales, the current Chief Operating Officer, is set to take over the roles of President and CEO and join the Board at that time.
Dziedzic’s tenure, spanning eight years, is noted for significant growth and value creation within the company, marked by a strategic focus on high-growth markets and investments in differentiated technologies. Under his leadership, the company has achieved a robust 10.35% revenue growth in the last twelve months, maintaining a strong current ratio of 2.95, indicating solid financial stability. Pamela G. Bailey, Chair of the Board, commended Dziedzic for his leadership and the establishment of the Integer Production System, which has contributed to the company’s financial success.
Khales, who joined Integer in 2018 as President of the Cardio & Vascular business, has been pivotal in doubling sales in seven years and driving above-market growth. As COO, he has been responsible for overseeing Integer’s business units and global operations. Khales expressed gratitude for the appointment and recognized Dziedzic’s mentorship and the company’s current momentum.
Integer also released its first-quarter financial results for 2025 in a separate press release and will hold a conference call to discuss the details. The company, which operates under the brands Greatbatch Medical® and Lake Region Medical®, continues to be a strategic partner in the medical device sector. With analysts maintaining a strong buy consensus and setting price targets up to $160, investors seeking detailed analysis can access comprehensive research reports and additional insights through InvestingPro, which offers extensive coverage of Integer Holdings among its 1,400+ detailed US equity reports.
The transition plan includes Dziedzic serving as an advisor until March 31, 2026, to ensure a smooth handover of leadership. This announcement is based on a press release statement from Integer Holdings Corporation.
In other recent news, Integer Holdings Corporation is preparing for a potential impact of $1 to $5 million on its full-year adjusted operating income due to recent U.S. trade tariffs. This projection aligns with the company’s previous estimates and incorporates both current and additional tariffs announced on April 2. The company is set to release its first-quarter financial results on April 24, 2025. In related developments, S&P Global Ratings has upgraded the debt rating of Integer’s subsidiary, Greatbatch Ltd., from ’BB-’ to ’BB’. This follows the completion of a $1 billion convertible notes issuance aimed at refinancing existing debt and enhancing liquidity. Raymond James has initiated an Outperform rating for Integer Holdings, setting a price target of $145, citing the company’s strong position in the medical device industry and potential for growth. Meanwhile, Integra Resources Corp. reported its fourth-quarter earnings and revenue, which met analyst expectations, following its acquisition of the Florida Canyon mine. Integra produced 10,984 ounces of gold and sold 11,382 ounces, marking its transition to a gold producer.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.